mounjaro glp 1 agonist (tirzepatide) for the Treatment of Type 2 Diabetes, USA Mounjaro Science: How GIP &
Description
Kristina Tatum with VCU is the lead author

Hypoglycemia can occur in individuals with type 2 diabetes, especially when they are taking insulin or insulin secretagogues like sulfonylureas [39,40]

[DOI] [PMC free article] [PubMed] [Google Scholar] 5.Lee EJ, Choi M, Ahn SB, Yoo JJ, Kang SH, Cho Y, Song DS, Koh H, Jun DW, Lee HW
Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS

But what makes GLP-1 agonists so revolutionary

Since GLP-1 receptor agonists became widely prescribed, regulatory agencies and researchers have monitored potential pancreatic safety signals
